Holt, ACT, Australia

David I Last

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1994.


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 29(Granted Patents)


Company Filing History:

goldMedal1 out of 834,350 
Other
 patents

Years Active: 1994

Loading Chart...
1 patent (USPTO):Explore Patents

Title: David I Last - Innovator in Plant Biotechnology

Introduction

David I Last is a notable inventor based in Holt, ACT, Australia. He has made significant contributions to the field of plant biotechnology, particularly in enhancing gene expression in monocotyledonous plants. His innovative work has led to the development of a unique recombinant promoter molecule.

Latest Patents

David I Last holds a patent for a "Recombinant promoter for gene expression in monocotyledonous plants." This patent involves a recombinant promoter molecule designed to enhance the expression of a plant-expressible structural gene in monocot plant cells. The invention comprises a plurality of enhancer elements selected from the group consisting of ARE and OCS elements, a truncated plant-expressible promoter, and an intron. He has 1 patent to his name.

Career Highlights

Throughout his career, David has focused on advancing the understanding of gene expression in plants. His work has implications for agricultural biotechnology, potentially leading to improved crop yields and resistance to environmental stresses.

Collaborations

David I Last has collaborated with notable colleagues in his field, including Mark R Olive and Philip John Larkin. These partnerships have contributed to the advancement of research in plant biotechnology.

Conclusion

David I Last is a prominent figure in the realm of plant biotechnology, with a focus on enhancing gene expression in monocotyledonous plants. His innovative contributions continue to impact the field significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…